Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer’s Bourla On Paxlovid Patent Deal And Why A Similar Approach Won't Work For Comirnaty

Nov 17 2021

• By Alaric DeArment

Coronavirus — Pfizer CEO Albert Bourla discussed the latest news about the company's COVID-19 pill at the STAT Summit • Source: Shutterstock

Related Content

Could This Be Pfizer’s Biggest Week At The US FDA For COVID Products?

Nov 17 2021

Pfizer & MPP Sign Deal For Generics Of COVID-19 Candidate Paxlovid

Nov 16 2021

Pfizer’s Oral COVID-19 Pill Paxlovid Tops Merck’s Molnupiravir

Nov 05 2021

Comirnaty Gives Booster Shot To Pfizer Q3 Sales

Nov 02 2021

Coronavirus Update: Gates Foundation To Give $120m For Molnupiravir Access

Oct 21 2021

Related Companies

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Ridgeback Biotherapeutics LP

Merck & Co., Inc.

Sangamo Therapeutics, Inc.

Additional Topics

Coronavirus COVID-19 Companies Intellectual Property Research & Development

More from COVID-19

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window